Koselugo
Payments companies reported to CMS as associated with Koselugo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Koselugo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Koselugo
These are the largest totals companies reported as associated with Koselugo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zsila Sadighi | Houston, TX | Neurology (Psychiatry & Neurology) | $185,371.61 |
| Hamza Gorsi | Providence, RI | Pediatric Hematology-Oncology | $64,027.10 |
| Michael Mangum | Phoenix, AZ | Pediatric Hematology-Oncology | $54,344.28 |
| Miriam Bornhorst | Chicago, IL | Pediatric Hematology-Oncology | $52,807.84 |
| Kaleb Yohay | New York, NY | Neurology With Special Qualifications In Child Neurology | $51,713.88 |
| Dana Obzut | Tampa, FL | Pediatric Hematology-Oncology | $48,184.53 |
| Audrey Green-Murphy | Madera, CA | Pediatric Hematology-Oncology | $46,719.43 |
| Alyssa Reddy | Birmingham, AL | Neurology With Special Qualifications In Child Neurology | $45,651.98 |
| Kasey Rangan | Los Angeles, CA | Pediatrics (Nurse Practitioner) | $43,904.19 |
| Christopher Moertel | Minneapolis, MN | Pediatric Hematology-Oncology | $38,722.18 |
Prescribed Koselugo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.